-
Ensuring Diversity and Equity in Parkinson’s Disease Research and Care
… of measures that can be used to assess walking ability in research and healthcare. In this project, we will assess … a meaningful measure of their experiences. Impact on Diagnosis/Treatment of Parkinson’s disease: Taking into account the views of people with PD, we will ensure …
-
Breaking News from D.C.: President Biden Has Signed the National Plan to End Parkinson's Act Into Law
July 2, 2024
… Biden signs the National Plan to End Parkinson's Act into law. Photo courtesy of the Biden administration. Update … families, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) applauds Congress for this historic step … than 70,000 messages to Congress urging their support. And nearly 1,000 advocates joined MJFF to meet directly with …
-
MJFF Research Support
… support and resources to those invested in Parkinson’s research— across academia, industry, government, venture … more. Data Resources We believe data sharing is critical to research progress. Through our sponsored and funded studies, we collaborate with the research community to collect and distribute a multitude of …
-
Research Tools Consortium
… J. Fox Foundation (MJFF) spearheads the Parkinson's Disease Research Tools Consortium. This precompetitive consortium … and develop new pre-clinical tools to address unmet research needs and accelerate experiments. Foundation Strategy Parkinson’s researchers need accessible and well-characterized …
-
Research Tools Consortium
… J. Fox Foundation (MJFF) spearheads the Parkinson's Disease Research Tools Consortium. This precompetitive consortium … and develop new pre-clinical tools to address unmet research needs and accelerate experiments. Foundation Strategy Parkinson’s researchers need accessible and well-characterized …
-
Collaborative Research Opportunities
… a range of resources available to industry at no cost for research that is aligned with our scientific priorities. We … you share our goal of helping Parkinson's patients through research, we want to hear from you. You can review our … our collaborations in action. See All Partners Investing in Early-stage Therapies We fund high-risk, high-reward, …